Calamos Advisors LLC Astrazeneca PLC Transaction History
Calamos Advisors LLC
- $15.7 Billion
- Q1 2025
A detailed history of Calamos Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Calamos Advisors LLC holds 12,186 shares of AZN stock, worth $887,506. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,186
Previous 12,139
0.39%
Holding current value
$887,506
Previous $795,000
12.58%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.16 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.96 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.59 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.32 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.28 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $226B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...